Moody Aldrich Partners »

Capricor Therapeutics shares owned by Moody Aldrich Partners

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Moody Aldrich Partners from 13F filings

Historical chart of Moody Aldrich Partners investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Moody Aldrich Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Moody Aldrich Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.0M 209k 28.86

More positions owned by Moody Aldrich Partners

Praxis Precision Medicines I Com New (PRAX)
Cadence Bank
Independent Bank (INDB)
Bridgebio Pharma (BBIO)
Columbia Banking System (COLB)
Wintrust Financial Corporation (WTFC)
Piper Jaffray Companies (PIPR)
Meta Financial (CASH)
Axsome Therapeutics (AXSM)
Portland Gen Elec Com New (POR)
Viatris (VTRS)
Karman Hldgs Common Stock (KRMN)
Protagonist Therapeutics (PTGX)
Element Solutions (ESI)
Modine Manufacturing (MOD)

View all positions for Moody Aldrich Partners

Top funds holding Capricor Therapeutics

BlackRock
Susquehanna International
Vanguard Group
Point72 Asset Management
Suvretta Capital Management
Tang Capital Management
Citadel Advisors
Geode Capital Management
Caption Management
State Street Corporation
Darwin Global Management
Diadema Partners
Soleus Capital Management
J. Goldman & Co
Ikarian Capital

View all funds holding Capricor Therapeutics